The Global Gene Therapy Market to grow at a CAGR of 22.42% during the period 2018-2022.
Gene therapy is one of the most recent innovations in the pharmaceutical industry for the treatment of serious, life-threatening diseases, typically in the areas of oncology and cardiovascular. It is the usage of modified gene injected into the patient's body primarily through virus as a vector. This transmitted gene reaches the intended site to kill or treat the infected cell, thus curing the disease.
One trend affecting this market is the growing research in gene therapy for CVDs and orphan diseases. The increasing prevalence of CVDs and the urgency to treat the diseases in less time is leading the major companies to move towards more effective therapies, such as gene therapy.
According to the report, one driver influencing this market is the entry of novel molecules during the forecast period. Presently, gene therapy is one of the most advanced treatment methods in the pharmaceutical industry and there is a strong pipeline for the development of gene therapy in the forecast period.
Further, the report states that one challenge affecting this market is the high treatment costs. The competition between standard reference drug and generic drugs is intense as generics have the same therapeutic activity as the reference drug.
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
Market segmentation analysis
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
Market sizing 2017
Market size and forecast 2017-2022
PART 07: MARKET SEGMENTATION BY THERAPY AREA
Segmentation by therapy area
Comparison by therapy area
Market opportunity by therapy area
PART 08: PIPELINE
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
Key leading countries
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
Growing research in gene therapy for CVDs and orphan diseases